Supplements should fill gaps, not replace food
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: a randomized controlled trial in patients with type 2 diabetes
There is no such thing as the best form of carnitine, only the right form
It affects people at every stage of treatment, from those preparing for their very first dose to experienced users who suddenly wonder if they have been doing it wrong all along
Many patients exhibit: Heat sensitivity Stress-triggered flushing Rapid redness changes Burning sensations This suggests dysregulation involving: Mast cells Nervous system signaling Blood vessel reactivity Stress, poor sleep, and cortisol dysregulation may amplify these pathways
Purification, kinetic properties, and physiological roles